Formaldehyde scavenging from peritoneal dialysis solutions using reduced aminothiol compounds

Nephrology

Volumn 9, Issue 2, 2004, Pages 65-72

  Bird, Stephen D ^a   Legge, Michael ^a   Walker, Robert J ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Aldehyde; Aldehyde scavenger; Bioincompatibility; Carbonyl compound; Cryopreservatlon; Peritoneal dialysis solutions; Thiazolidine

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALDEHYDE; AMINOTHIOL; CALCIUM CHLORIDE; CYSTEINE; FORMALDEHYDE; GLUCOSE; LACTIC ACID; MAGNESIUM CHLORIDE; MERCAPTAMINE; SODIUM CHLORIDE; TIMONACIC;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CRYOPROTECTION; EMBRYO; FREEZE DRYING; KINETICS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SCAVENGING SYSTEM; TISSUE;

CYSTEAMINE; CYSTEINE; DIALYSIS SOLUTIONS; FORMALDEHYDE; MAGNETIC RESONANCE SPECTROSCOPY; PERITONEAL DIALYSIS;

EID: 1942435973     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2003.00236.x     Document Type: Article

References (40)

1. Taylor RB, Jappy BM, Neil JM. Kinetics of dextrose degradation under autoclaving conditions. J. Pharm. Pharmacol. 1971; 23: 121-9.
2. Ulbricht RJ, Northup SJ, Thomas JA. A review of 5-hydroxymethylfurfural (HMF) in parenteral solutions. Fund. Appl. Toxicol. 1984; 4: 843-53.
3. Henderson IS. Composition of peritoneal dialysis solutions: potential hazards. Blood Purif 1989; 7: 86-94.
4. Taylor RB, Sood VC. An h.p.l.c. study of the initial stages of dextrose decomposition in neutral solution. J. Pharm. Pharmacol. 1979; 30: 510-11.
5. Nilsson-Thorell CG, Muscalu N, Andren AHG, Kjellstrand PTT, Wieslander AP. Heat sterilization of fluids for peritoneal dialysis gives rise to aldehydes. Perit. Dial. Int. 1993; 13: 208-13.
6. Legge M, Lash GE, Bird SD, Walker RJ. Formaldehyde in heat sterilized peritoneal dialysis solutions: scavenging system for its removal. Perit. Dial. Int. 1998; 18: 228-31.
7. Karran G, Legge M. Non-enzymatic formation of formaldehyde in mouse oocyte freezing mixtures. Hum. Reprod. 1996; 11: 101-6.
8. Wieslander AP, Nordin MK, Kjellstrand PTT, Boberg UC. Toxicity of peritoneal dialysis fluids on cultured fibroblasts, L-929. Kidney Int. 1991; 40: 77-9.
9. Mahadevan MM, McIntosh Q, Miller MM, Breckinridge SM, Maris M, Moutos DM. Formaldehyde in cryoprotectant propanediol and effect on mouse zygotes. Hum. Reprod. 1998; 13: 979-82.
10. Witowski J, Korybalska K, Wisniewska J et al. Effects of glucose degradation products on human peritoneal mesothelial cell function. J. Am. Soc. Nephrol. 2000; 11: 729-39.
11. Conaway CC, Whysner J, Verna LK, Williams GM. Formaldehyde mechanistic data and risk assessment: endogenous protection from DNA adduct formation. Pharmacol. Ther. 1996; 71: 29-55.
12. Grafström RC, Fornace AJ, Autrup H, Lechner JF, Harris CC. Formaldehyde damage to DNA and inhibition of DNA repair in human bronchial cells. Science 1983; 220: 216-18.
13. Holt K, Bennett M, Chojkier M. Acetaldehyde stimulates collagen and noncollagen protein production by human fibroblasts. Hepatology 1984; 4: 843-8.
14. Brenner DA, Chojkier M. Acetaldehyde increases collagen gene transcription in cultured human fibroblasts. J. Biol. Chem. 1987; 262: 17 690-5.
15. Chojkier M, Houglum K, Solis-Herruzo J, Brenner DA. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? J. Biol. Chem. 1989; 264: 16 957-62.
16. Schubert MP. Compounds of thiol acids with aldehydes. J. Biol. Chem. 1936; 114: 341-9.
17. Nagasawa HT, Goon GJW, Shirota FN. Epimerization at C-2 of 2-substituted thiazolidine-4-carboxylic acids. J. Heterocyclic Chem. 1981; 18: 1047-51.
18. Linden T, Cohen A, Deppisch R, Kjellstrand P, Wieslander A. 3,4-Dideoxyglucosone-3-ene (3,4-DGE): a cytotoxic glucose degradation product in fluids for peritoneal dialysis. Kidney Int. 2002; 62: 697-703.
19. Wieslander AP, Nordin MK, Martinson E, Kjellstrand PTT, Boberg UC. Heat sterilized PD-fluids impair growth and inflammatory responses of cultured cell lines and human leukocytes. Clin. Nephrol. 1993; 39: 343-8.
20. Klein SM, Cohen MG, Cederbaum ALL. Production of formaldehyde during metabolism of dimethylsulphoxide. Biochemistry 1981; 20: 6006-12.
21. Morgan KT. A brief review of formaldehyde carcinogenesis in relation to rat nasal pathology and human health risk assessment. Toxicol. Pathol. 1997; 25: 291-307.
22. IARC. Wood dust and formaldehyde. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. IARC Press, 1995; 217-362.
23. Lash GE, Bird SD, Legge M, Walker RJ. Scavenging reactive chemical species of glucose degradation from peritoneal dialysis solutions with thiol compounds. Kidney Int. 1997; 51: 1330.
24. Wondrak GT, Cervantes-Laurean D, Roberts MJ et al. Identification of α-dicarbonyl scavengers for cellular protection against carbonyl stress. Biochem. Pharmacol. 2002; 63: 361-73.
25. Saez G, Thornalley PJ, Hill HA, Hems R, Bannister JV. The production of free radicals during the autoxidation of cysteine and their effect on isolated rat hepatocytes. Biochim. Biophys. Acta 1982; 719: 24-31.
26. Jencks WP. Catalysis in Chemistry and Enzymology. New York, McGraw-Hill; 1969.
27. Kallen RG. The mechanism of reactions involving Schiffs base intermediates. Thiazolidine formation from L-cysteine and formaldehyde. J. Am. Chem. Soc. 1971; 93: 6236-48.
28. Williamson JM, Meister A. Stimulation of hepatic glutathione formation by administration of L-2-oxothiazolidine-4-carboxylate, a 5-oxo-L-prolinase substrate. Proc. Natl Acad. Sci. USA 1981; 78: 936-9.
29. Deneke SM. Thiol-based antioxidants. Curr. Top. Cell. Regul. 2000; 36: 151-80.
30. Roberts JC, Koch KE, Detrick SR, Warters RL, Lubec G. Thiazolidine prodrugs of cysteamine and cysteine as radioprotective agents. Rad. Res. 1995; 143: 203-13.
31. Nagasawa HT, Goon DJW, Zera RT, Yuzon DL. Prodrugs of 1-cysteine as liver-protective agents. 2 (RS)-methylthiazolidine-4 (R.)-carboxylic acid, a latent cysteine. J. Med. Chem. 1982; 25: 489-91.
32. Nagasawa HT, Goon DJW, Muldoon WP, Zera RT. 2-Substituted thiazolidine-4 (R.)-carboxylic acids as prodrugs of 1-cysteine. Protection of mice against acetaminophen hepatotoxicity. J. Med. Chem. 1984; 27: 591-6.
33. Wlodek L, Czubak J. The antioxidative properties of thiazolidine derivatives. Pol. J. Pharmacol. Pharm. 1989; 41: 369-75.
34. Terzuoli L, Leoncini R, Pagani R. et al. Some chemical properties and biological role of thiazolidine compounds. Life Sci. 1998; 63: 1251-67.
35. Ratner S, Clark HT. The action of formaldehyde upon cysteine. J. Am. Chem. Soc. 1937; 59: 200-6.
36. Weber HU, Fleming JF, Miquel J. Thiazolidine-4-carboxylic acid, a physiologic sulfhydryl antioxidant with potential value in geriatric medicine. Arch. Gerontol. Geriatr. 1982; 1: 299-310.
37. Werner LH, Wettstein A, Miescher K. The synthesis of acylated dipeptides similar to penicillin. Helv. Chim. Acta 1947; 30: 432-40.
38. Ryzewski J, Roszkowski-Sliz W, Krzystyniak K. The action of thiols on lymphocyte membranes. Immunology 1976; 31: 145-9.
39. Nerland DE, Benz FW, Babiuk C. Effects of cysteine isomers and derivatives on acute acrylonitrile toxicity. Drug Metab. Rev. 1989; 20: 233-46.
40. Gomez MR, Benzick AE, Rogers LK, Heird WC, Smith CV. Attenuation of acetaminophen hepatotoxicity in mice as evidence for the bioavailability of the cysteine in D-glucose-L-cysteine in vivo. Toxicol. Lett. 1994; 70: 101-8.